GeneDx Holdings Corp. Class A (WGS) Dividend History

GeneDx Holdings Corp. Class A (WGS) is a biotechnology company specializing in genetic testing and diagnostics. It offers comprehensive genomic services, including whole genome sequencing, genetic variant analysis, and clinical testing to support personalized medicine and rare disease diagnosis. The company focuses on leveraging advanced genomic technologies to aid healthcare providers and researchers in identifying genetic conditions.

333 Ludlow Street, Stamford, CT, 06902
Phone: 617 780 8742
Website: https://www.genedx.com

Dividend History

GeneDx Holdings Corp. Class A currently does not pay dividends

Company News

Why GeneDx Holdings Stock Is Plunging Today

GeneDx Holdings (WGS) stock plunged 42.9% despite reporting better-than-expected Q1 revenue and earnings. Investors were disappointed by the smaller-than-usual revenue beat and a decline in test volume. The company raised its full-year revenue guidance, but its valuation appears expensive compared to industry peers.

The Motley Fool
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million

GeneDx announced plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation, to create a leading platform for rare disease diagnostics and newborn screening. The $51 million deal is expected to accelerate genomic newborn screening, enhance NICU testing capabilities, and expand GeneDx's global reach.

Benzinga
GeneDx Stock Was up 2,700% in 2024 — Can It Keep Rising?

GeneDx, a leader in genome and exome testing, saw its stock price surge over 2,700% in 2024. The company's strong earnings and revenue growth in Q4 2024 have continued into 2025, with the stock price spiking 47% on Tuesday. However, a recent negative report by Grizzly Research has raised concerns about the company's growth.

Investing.com
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year

GeneDx, a genetic testing specialist, saw its stock rise over 6,000% in the past 12 months, outperforming Nvidia's 5-year return. While the company's exome sequencing business is growing, the diagnostics industry is highly competitive, and the stock's valuation is steep, making it a risky investment.

The Motley Fool

Featured Companies: DGX NVDA
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?

Several mid-cap stocks, including Globalstar, V.F. Corp, and Madrigal Pharmaceuticals, were among the top gainers last week. The companies reported positive financial results and business updates, leading to the stock price increases.

Benzinga

Featured Companies: GSAT MDGL NXT OMCL PRCT VFC

Dividend data last updated 06/07/2025 20:29:59 UTC